Prevalence of co-existent neoplasia in clinically diagnosed pterygia in a UK population.


Journal

Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 06 03 2023
accepted: 17 05 2023
revised: 09 05 2023
medline: 7 12 2023
pubmed: 27 5 2023
entrez: 26 5 2023
Statut: ppublish

Résumé

Ocular surface squamous neoplasia (OSSN) and pterygia share risk factors and co-exist in only a minority of cases. Reported rates of OSSN in specimens sent as pterygium for histopathological analysis vary between 0% and nearly 10%, with the highest rates reported in countries with high levels of ultraviolet light exposure. As there is a paucity of data in European populations, the aim of this study was to report the prevalence of co-existent OSSN or other neoplastic disease in clinically suspected pterygium specimens sent to a specialist ophthalmic pathology service in London, United Kingdom. We performed a retrospective review of sequential histopathology records of patients with excised tissue submitted as suspected "pterygium" between 1997 and 2021. In total, 2061 specimens of pterygia were received during the 24-year period, with a prevalence of neoplasia in those specimens of 0.6% (n = 12). On detailed review of the medical records of these patients, half (n = 6) had the pre-operative clinical suspicion of possible OSSN. Of those cases without clinical suspicion pre-operatively, one was diagnosed with invasive squamous cell carcinoma of the conjunctiva. In this study, rates of unexpected diagnoses are reassuringly low. These results may challenge accepted dogma, and influence future guidance for the indications for submitting non-suspicious pterygia for histopathological analysis.

Identifiants

pubmed: 37237231
doi: 10.1038/s41433-023-02594-w
pii: 10.1038/s41433-023-02594-w
pmc: PMC10697954
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3757-3761

Informations de copyright

© 2023. The Author(s).

Références

JAMA Ophthalmol. 2015 Nov;133(11):1305-13
pubmed: 26378395
Br J Ophthalmol. 2021 Jun;105(6):775-778
pubmed: 32675060
Cornea. 2021 Aug 1;40(8):1002-1006
pubmed: 33201056
JAMA Ophthalmol. 2015 Nov;133(11):1314-21
pubmed: 26378623
Ocul Oncol Pathol. 2018 Jun;4(4):240-249
pubmed: 30643769
Curr Eye Res. 2022 Jul;47(7):978-981
pubmed: 35180019
Ophthalmology. 2013 Mar;120(3):445-450
pubmed: 23107578
Cornea. 2022 Feb 1;41(2):149-154
pubmed: 34690264
Curr Eye Res. 2015;40(12):1284-7
pubmed: 25546258
Eye Vis (Lond). 2018 Jun 12;5:13
pubmed: 29942817
Br J Ophthalmol. 2011 Apr;95(4):592
pubmed: 21217137
Int Ophthalmol. 2020 Jul;40(7):1781-1788
pubmed: 32198608
Arch Ophthalmol. 2009 Jan;127(1):31-2
pubmed: 19139334
Br J Ophthalmol. 2006 Jan;90(1):109-13
pubmed: 16361679
Eye (Lond). 2012 Feb;26(2):202-11
pubmed: 22134594
Ophthalmic Epidemiol. 1999 Sep;6(3):219-28
pubmed: 10487976
Saudi J Ophthalmol. 2016 Apr-Jun;30(2):113-6
pubmed: 27330387
J Ophthalmol. 2021 Mar 19;2021:6623794
pubmed: 33828861
Ophthalmology. 2013 Jul;120(7):1337-40
pubmed: 23499063
Trop Med Int Health. 2013 Dec;18(12):1424-43
pubmed: 24237784

Auteurs

Hibba Quhill (H)

Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK. hibba.quhill@nhs.net.
Ocular Oncology Service, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. hibba.quhill@nhs.net.

Tejal Magan (T)

Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK.

Caroline Thaung (C)

Department of Eye Pathology, UCL Institute of Ophthalmology, London, UK.

Mandeep S Sagoo (MS)

Ocular Oncology Service, Moorfields Eye Hospital NHS Foundation Trust, London, UK.
NIHR Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH